Answers are grounded in this paper and cite their sources.
A pilot study of newborn screening for Fabry disease was performed in Okinawa, Japan. A total of 2,443 neonates were screened using dried blood spot samples over 7 years starting in 2007. Of 13 neonates determined to have low α-galactosidase A (GLA) activity, one boy had a new missense mutation, p.G144D of the GLA gene. This mutation was considered to be a late-onset type, as evaluated based on plasma globotriaosylsphingosine levels and family history.
No takes yet. Share an insight, caveat, or question.
Chinen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: